Lenskart
PublicLenskart is now publicly traded
The data on this page reflects Lenskart's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 31, 2025
Last Round
Growth Equity
Oct 24, 2025
Est. Valuation at Exit
$8B
Total Funding Raised
$2.21B
Company Overview
Lenskart is an omnichannel eyewear company that designs, manufactures, and retails prescription eyeglasses, sunglasses, and contact lenses through its online platforms and physical stores.
Sector
eCommerce, Consumer Goods
AI Layer
Application
Keywords
Lenskart Comparables
Compare Lenskart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Titan Company | 81% | |
| Specsmakers | 79% | |
| Eyewa | 78% |
For institutional investors. Book with your work email.
Lenskart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 31, 2025 | ||||
| Growth Equity | Oct 24, 2025 | ||||
| Early Funding | Jul 1, 2024 | ||||
| Secondary | Jun 3, 2024 | ||||
| Series J | Jun 15, 2023 | ||||
Series I | Mar 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lenskart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series G |
| ChrysCapital | Series J |
| Temasek | Series I, Secondary, Series H |
| Intensive Fiscal Services | IPO |
| Steadview Capital | Secondary |
| Kohlberg Kravis Roberts | Series H |
| Unilazer Ventures | Series B |
For institutional investors. Book with your work email.
Lenskart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.